Rigel (RIGL) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on Rigel Pharmaceuticals (RIGL), as it has been recently upgraded to a Zacks Rank #2 (Buy).

Yahoo FinanceMay 11 00:00

US$5.15 - That's What Analysts Think Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Is Worth After These Results

The analysts might have been a bit too bullish on Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), given that the company fell short of expectations when it released its first-quarter results last week.

Simply Wall StMay 10 18:26

Rigel Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

Rigel Pharmaceuticals Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.

BenzingaMay 9 00:50

Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Rigel Pharmaceuticals Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow JonesMay 8 21:47

HC Wainwright & Co. : Rigel Pharmaceuticals (RIGL.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $15.00.

HC Wainwright & Co. : Rigel Pharmaceuticals (RIGL.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $15.00.

Zhitong FinanceMay 8 21:41

HC Wainwright & Co. Reiterates Buy on Rigel Pharmaceuticals, Maintains $15 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and maintains $15 price target.

BenzingaMay 8 21:37